Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1778441012 | Hydralazine hydrochloride + hydrochlorothiazide + reserpine | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3490636011 | Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3494831014 | Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine | Is a | Product containing hydrochlorothiazide and reserpine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine | Is a | Product containing hydralazine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine | Has active ingredient | Hydrochlorothiazide (substance) | false | Inferred relationship | Some | ||
| Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine | Has active ingredient | Reserpine (substance) | false | Inferred relationship | Some | ||
| Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine | Has active ingredient | Centrally acting hypotensive agent (substance) | false | Inferred relationship | Some | ||
| Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine | Has active ingredient | Hydralazine hydrochloride | false | Inferred relationship | Some | ||
| Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine | Is a | Hydralazine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some | ||
| Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine | Is a | Medicinal product acting as vasodilator (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Is a | False | Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
FHIR